from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3061c/fadE22

LFCtreatmentdescriptionclass of inhibitor

0.611

Amikacinug/mL Amikacintranslation

0.280

Cap5-10ug/mL Capreomycintranslation

-0.039

Rox10-50 ug/mL Roxithromycintranslation

0.616

SM2-5 ug/mL Streptomycintranslation

-0.575

Tet5-10 ug/mL Tetracyclinetranslation

-0.398

Rif0.2-5ug/mL Rifampicintranscription

-0.092

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.084

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.124

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.133

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.891

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.281

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.441

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.322

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.719

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.629

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.176

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.291

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.963

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.982

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.100

KCN5-20 ug/mL Potassium cyaniderespiration

-0.682

NaN30.2-2 mM Sodium aziderespiration

-0.262

Nigericin50 uM Nigericinrespiration

0.206

TRC10-150 ug/mL Triclosanrespiration

-0.503

TRZ10-25 ug/mL Thioridazinerespiration

0.893

Valinomycin0.5-10 uM Valinomycinrespiration

-0.661

ZnSO42 mM ZnSO4respiration

2.687

menadione6-10 ug/mL Menadionerespiration

-0.291

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.167

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.255

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.779

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.081

NRP_1Non-replicating persistence stage 1dosRassociated

-0.605

Amp0.2mg/mL AmpicillincellWall

-0.747

Cephalexin20-100 ug/mL CephalexincellWall

0.148

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.100

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.442

EMB10-20 ug/mL EthambutolcellWall

0.741

Eta12-40 ug/mL EthionamidecellWall

-0.517

INH0.2-0.4 ug/mL IsoniazidcellWall

0.151

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.938

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.271

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.246

BZA0.12 mg/mL BenzamidearomaticAmides

0.594

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.520

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.261

H2O24 mM hydrogen peroxideDNAdamaging

-0.493

Levo10 ug/mL LevofloxacinDNAdamaging

-0.270

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.837

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.329

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.101

UVUV-irradiationDNAdamaging

1.899

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.177

Antimycin12.5-50 ug/mL Antimycin A?

-0.501

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.447

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.002

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.175

PA8240.2-2 ug/mL PA-824?

0.552

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.053

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.234

Verapamil50 uM Verapamil?

-0.220

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.483

methoxatin10-20 ug/mL Methoxatin?